Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2021-06-11 Sale | 2021-06-15 7:19 pm | Dicerna Pharmaceuticals Inc | DRNA | Ciappenelli Robert D. Chief Commercial Officer | 30,000 | $37 | $1,110,000 | 563,773 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2021-12-28 Equity Swap | 2021-12-29 4:19 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | Ciappenelli Robert D. Chief Strategy Officer | 14,813 | $38.25 | 0 (Direct) | View |
2021-12-28 Disposition | 2021-12-29 4:19 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | Ciappenelli Robert D. Chief Strategy Officer | 435,244 | $0 | 0 (Direct) | View |
2021-12-15 Tax Withholding | 2021-12-17 4:18 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | Ciappenelli Robert D. Chief Strategy Officer | 1,241 | $38.05 | 25,088 (Direct) | View |
2021-12-15 Exercise | 2021-12-17 4:18 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | Ciappenelli Robert D. Chief Strategy Officer | 3,425 | $0 | 25,088 (Direct) | View |
2021-12-13 Exercise | 2021-12-14 9:02 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | Ciappenelli Robert D. Chief Strategy Officer | 8,856 | $22.58 | 88,773 (Direct) | View |
2021-12-13 Exercise | 2021-12-14 9:02 pm | N/A 2030-01-07 | Dicerna Pharmaceuticals Inc | DRNA | Ciappenelli Robert D. Chief Strategy Officer | 8,856 | $0 | 88,773 (Direct) | View |
2021-06-11 Exercise | 2021-06-15 7:19 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | Ciappenelli Robert D. Chief Commercial Officer | 30,000 | $15.61 | 563,773 (Direct) | View |
2021-06-11 Exercise | 2021-06-15 7:19 pm | N/A 2029-06-30 | Dicerna Pharmaceuticals Inc | DRNA | Ciappenelli Robert D. Chief Commercial Officer | 30,000 | $0 | 563,773 (Direct) | View |
2021-01-12 Option Award | 2021-01-12 9:35 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | Ciappenelli Robert D. Chief Commercial Officer | 75,200 | $0 | 96,298 (Direct) | View |
2021-01-08 Tax Withholding | 2021-01-12 9:35 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | Ciappenelli Robert D. Chief Commercial Officer | 2,002 | $23.29 | 96,298 (Direct) | View |
2021-01-08 Exercise | 2021-01-12 9:35 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | Ciappenelli Robert D. Chief Commercial Officer | 5,775 | $0 | 96,298 (Direct) | View |
2020-01-08 Option Award | 2020-01-10 8:00 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | Ciappenelli Robert D. Chief Commercial Officer | 108,100 | $0 | 108,100 (Direct) | View |